These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35170874)

  • 1. TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function.
    Taga A; Peyton MA; Goretzki B; Gallagher TQ; Ritter A; Harper A; Crawford TO; Hellmich UA; Sumner CJ; McCray BA
    Ann Clin Transl Neurol; 2022 Mar; 9(3):375-391. PubMed ID: 35170874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Properties of TRPV4 Mutant Channels Present in Polycystic Kidney Disease Patients.
    Hernández-Vega AM; Llorente I; Sánchez-Hernández R; Segura Y; Tusié-Luna T; Morales-Buenrostro LE; García-Villegas R; Islas LD; Rosenbaum T
    Function (Oxf); 2024 Sep; 5(5):. PubMed ID: 38984987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: a report of three patients.
    Cho TJ; Matsumoto K; Fano V; Dai J; Kim OH; Chae JH; Yoo WJ; Tanaka Y; Matsui Y; Takigami I; Monges S; Zabel B; Shimizu K; Nishimura G; Lausch E; Ikegawa S
    Am J Med Genet A; 2012 Apr; 158A(4):795-802. PubMed ID: 22419508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound heterozygous TRPV4 mutations in two siblings with a complex phenotype including severe intellectual disability and neuropathy.
    Thibodeau ML; Peters CH; Townsend KN; Shen Y; Hendson G; Adam S; Selby K; Macleod PM; Gershome C; Ruben P; Jones SJM; ; Friedman JM; Gibson WT; Horvath GA
    Am J Med Genet A; 2017 Nov; 173(11):3087-3092. PubMed ID: 28898540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo
    Ragamin A; Gomes CC; Bindels-de Heus K; Sandoval R; Bassenden AV; Dib L; Kok F; Alves J; Mathijssen I; Medici-Van den Herik E; Eveleigh R; Gayden T; Pullens B; Berghuis A; van Slegtenhorst M; Wilke M; Jabado N; Mancini GMS; Gomez RS
    J Med Genet; 2022 Mar; 59(3):305-312. PubMed ID: 33685999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPV4 axonal neuropathy spectrum disorder.
    McEntagart M
    J Clin Neurosci; 2012 Jul; 19(7):927-33. PubMed ID: 22617546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined clinical, structural, and cellular studies discriminate pathogenic and benign TRPV4 variants.
    Berth SH; Vo L; Kwon DH; Grider T; Damayanti YS; Kosmanopoulos G; Fox A; Lau AR; Carr P; Donohue JK; Hoke M; Thomas S; Karim C; Fay AJ; Meltzer E; Crawford TO; Gaudet R; Shy ME; Hellmich UA; Lee SY; Sumner CJ; McCray BA
    Brain; 2024 Jul; ():. PubMed ID: 39021275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathy-causing TRPV4 mutations disrupt TRPV4-RhoA interactions and impair neurite extension.
    McCray BA; Diehl E; Sullivan JM; Aisenberg WH; Zaccor NW; Lau AR; Rich DJ; Goretzki B; Hellmich UA; Lloyd TE; Sumner CJ
    Nat Commun; 2021 Mar; 12(1):1444. PubMed ID: 33664271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPV4-pathy, a novel channelopathy affecting diverse systems.
    Dai J; Cho TJ; Unger S; Lausch E; Nishimura G; Kim OH; Superti-Furga A; Ikegawa S
    J Hum Genet; 2010 Jul; 55(7):400-2. PubMed ID: 20505684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia.
    Rock MJ; Prenen J; Funari VA; Funari TL; Merriman B; Nelson SF; Lachman RS; Wilcox WR; Reyno S; Quadrelli R; Vaglio A; Owsianik G; Janssens A; Voets T; Ikegawa S; Nagai T; Rimoin DL; Nilius B; Cohn DH
    Nat Genet; 2008 Aug; 40(8):999-1003. PubMed ID: 18587396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.
    Zimoń M; Baets J; Auer-Grumbach M; Berciano J; Garcia A; Lopez-Laso E; Merlini L; Hilton-Jones D; McEntagart M; Crosby AH; Barisic N; Boltshauser E; Shaw CE; Landouré G; Ludlow CL; Gaudet R; Houlden H; Reilly MM; Fischbeck KH; Sumner CJ; Timmerman V; Jordanova A; Jonghe PD
    Brain; 2010 Jun; 133(Pt 6):1798-809. PubMed ID: 20460441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPV4-associated skeletal dysplasias.
    Nishimura G; Lausch E; Savarirayan R; Shiba M; Spranger J; Zabel B; Ikegawa S; Superti-Furga A; Unger S
    Am J Med Genet C Semin Med Genet; 2012 Aug; 160C(3):190-204. PubMed ID: 22791502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene.
    Chen DH; Sul Y; Weiss M; Hillel A; Lipe H; Wolff J; Matsushita M; Raskind W; Bird T
    Neurology; 2010 Nov; 75(22):1968-75. PubMed ID: 21115951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The puzzle of TRPV4 channelopathies.
    Nilius B; Voets T
    EMBO Rep; 2013 Feb; 14(2):152-63. PubMed ID: 23306656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated osteoblastic differentiation in patient-derived dental pulp stem cells carrying a gain-of-function mutation of TRPV4 associated with metatropic dysplasia.
    Han X; Kato H; Sato H; Hirofuji Y; Fukumoto S; Masuda K
    Biochem Biophys Res Commun; 2020 Mar; 523(4):841-846. PubMed ID: 31954514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gain-of-function mutation in TRPV4 identified in patients with osteonecrosis of the femoral head.
    Mah W; Sonkusare SK; Wang T; Azeddine B; Pupavac M; Carrot-Zhang J; Hong K; Majewski J; Harvey EJ; Russell L; Chalk C; Rosenblatt DS; Nelson MT; Séguin C
    J Med Genet; 2016 Oct; 53(10):705-9. PubMed ID: 27330106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of TRPV4-Related disorders: From skeletal dysplasia to neuromuscular phenotype.
    Ürel-Demir G; Şimşek-Kiper PÖ; Öncel İ; Utine GE; Haliloğlu G; Boduroğlu K
    Eur J Paediatr Neurol; 2021 May; 32():46-55. PubMed ID: 33774370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic spectrum and incidence of TRPV4 mutations in patients with inherited axonal neuropathy.
    Echaniz-Laguna A; Dubourg O; Carlier P; Carlier RY; Sabouraud P; Péréon Y; Chapon F; Thauvin-Robinet C; Laforêt P; Eymard B; Latour P; Stojkovic T
    Neurology; 2014 May; 82(21):1919-26. PubMed ID: 24789864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPV4 expresses in bone cell lineages and TRPV4-R616Q mutant causing Brachyolmia in human reveals "loss-of-interaction" with cholesterol.
    Das R; Goswami C
    Biochem Biophys Res Commun; 2019 Oct; 517(4):566-574. PubMed ID: 31387748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in calmodulin-binding domains of TRPV4/6 channels confer invasive properties to colon adenocarcinoma cells.
    Arbabian A; Iftinca M; Altier C; Singh PP; Isambert H; Coscoy S
    Channels (Austin); 2020 Dec; 14(1):101-109. PubMed ID: 32186440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.